Outlook
On Industry
The Titanium Touch
EuroTimes Visits Duckworth and Kent, Ltd.Baldock, England And its
Managing Director Terry Waldock
By
John F. Henahan
Duckworth
and Kent, Ltd. is now the world's largest manufacturer of titanium
ophthalmic surgical instruments, but it didn't start out that way.
The
company first put down its roots in a small workshop in Hitchin,
located in the county of Hertfordshire, England. The original installation,
which was set up by two mechanical engineers--Fred Duckworth and
Harry Kent--in January 1959 is now an automobile sales showroom,
while the company's present production, marketing and administrative
staff of 50 occupy a modern 20,000 square foot two-story site in
the nearby town of Baldock.
Shortly
after they set up that that little workshop in Hitchin, Duckworth
and Kent moved to a small plant in Baldock where they were primarily
involved in highly secret contract engineering work for the UK Ministry
of Defense, and the idea that their names would be attached to one
of the world's foremost manufacturers of ophthalmic surgical instruments
was probably quite far from their minds. Terry Waldock, who is now
the company's Managing Director and sole owner was also trained
as a mechanical engineer and joined that tiny engineering operation
in 1963.
The
Door to Titanium and Ophthalmic Surgery Opens
It wasn't until about five years later, that Duckworth and Kent
would open the door to the entirely different world of ophthalmic
surgery. It began with an overture from a London surgeon named Dermot
Pierse, who asked them to produce four instruments for his own use
in cataract operations.
"For
a while after that, the surgical instrument side of our business
was little more than a hobby and over the next four years the situation
stayed pretty much the same. We also had the difficulty that they
were made from stainless steel and were prone to oxidation and we
never found a remedy to this until we were fortunate enough to meet
a metallurgist who suggested that we might be better off if we made
the instruments from titanium alloy. It appeared to have many advantages
in that it did not oxidise, and was very light and durable," Mr.
Waldock told EuroTimes.
"Up
until then, titanium alloy had been used primarily in the aerospace
industry, but not for surgical instruments. When we tried producing
surgical forceps and needle holders in titanium, we found that they
worked very well, and ever since then-in 1972-- we have used it
exclusively in the more than 1,000 ophthalmic surgical instruments
that we now produce for world-wide use."
An
Important
Transition
In 1983, the Duckworth and Kent commitment moved heavily into surgical
instrument manufacture, not only for eye surgery, but for neurosurgical
and ear nose and throat surgery. Initially, the instruments were
manufactured for Micra, another British company. After Mr. Waldock
bought Duckworth and Kent's shares in the company, the company terminated
its connection with Micra and began to produce its surgical instruments
independently as subcontractors for other companies, including Downs,
Metico, Thackray and Storz which all had their own names on the
instruments.
"That
was an important transition point for us, and in 1988 we decided
that we would put our own name on the instruments we produced in
order to expand our activities to the design, manufacture, marketing
and distribution of our own ophthalmic surgical products on a world-wide
basis. During that time we were gaining more expertise in working
with titanium, which required different manufacturing and engineering
techniques," Mr. Waldock points out.
"Since
we became involved in manufacturing instruments primarily for the
use of eye surgeons, we have found that the products we make have
been a close reflection of the many new developments that have marked
the growth of the field of ophthalmology over the last few years.
Our product line, which initially included instruments for performing
traditional cataract surgery, RK and AK, using micrometer diamond
knives, has expanded considerably to include the move to small incision
phacoemulsification procedures, such as instruments for performing
capsulorhexis and bi-manual irrigation and aspiration. We also find
ourselves making instruments for facilitating, radial keratotomy,
LASIK, INTACS and other forms of refractive surgery."
Keeping
abreast of the IOL revolution triggered by Harold Ridley more than
a half century ago Duckworth and Kent has also developed a strong
line of forceps, folders and injection devices required for implanting
traditional IOLs, as well as the new generation of foldable acrylic
and silicone lenses. In many cases, these instruments were developed
to meet the specific needs of individual surgeons as well as the
more commercial needs of large companies such as Alcon, Allergan
and Keravision.
"Our
relationship with Alcon has been a big plus for us. They had difficulties
in finding suppliers for instruments for implanting their foldable
Acrysof IOL and we were able to develop instruments for folding
and introducing their lenses, which they purchase and supply to
surgeons who implant them the lens in their patients throughout
the world.
"Recently
we have developed a new all-in-one instrument for introducing foldable
IOLs following phacoemulsification. It doesn't require a separate
cartridge and you just load the lens straight into the injector
and then implant it directly into the capsular bag. Initially it
was developed for the Acrysof 3-piece lens but it has also been
adapted to their one-piece lens as well as for silicone IOL implantation.
This is the only lens injector in the world that doesn't require
a cartridge," Mr. Waldock told EuroTimes, continuing:
"What
we are doing more and more is to work with companies to develop
the product they need for lens implantation or other products before
they introduce them to the market. In the past, the problem was
that IOL manufacturers often developed a lens without taking into
account the instruments they would need to introduce it into the
eye."
Over
the years, Duckworth and Kent has also been working closely with
individual surgeons to help them develop and perfect instruments
which they require for their own surgical needs. They include Spencer
Thornton, Leroy Bloomberg, Robert Osher, Richard Mackool, Azis Anis,
Miles Friedlander, Lee Nordan, Gilbert O'gawa and Gregory Ogawa
from the United States, Dr. Inamura and Takayuki Akahoshi from Japan,
Graham Barrett from Australia, Ioannis Pallikaris from Greece and
the late much-missed John Pearce from the UK to name just a few.
In
many cases, such as Dr. Thornton and Pallikaris, the instruments
that were developed reflect the company's growing commitment to
the rapidly emerging field of refractive surgery. For example, their
product line now includes instruments for LASIK developed by Dr.
Lucio Buratto, and other LASIK-oriented instruments developed by
Dr. Pallikaris, including his an arcutome which can be used in various
surgical procedures,
"Sometimes,
these surgeons may come to us only with an idea on a piece of paper.
We then draw up our own design and submit it to the surgeon for
his and approval. Then we make up a prototype and send the instrument
back for the surgeon to evaluate clinically. However, as in the
case of Dr. Pallikaris, there was a bit more to it than that. It
wasn't too difficult to make an arcutome that works; the problem
was to manufacture it from titanium -which is still quite an expensive
material-into a product that is clinically useful and isn't cost-prohibitive
in the marketplace, " Mr. Waldock notes.
Twenty-six
Instruments In Five Hours
Dr. Graham Barrett is another example of what can happen when the
Duckworth and Kent/surgeon relationship is really working.
"About
six years ago Graham was flying to Europe from Perth for an eye
congress and I asked him if we could get together in Heathrow Airport
in London to discuss some of his ideas. We sat down in a hotel room
at the airport for about five hours and in that time and between
us we agreed on the design of 26 different instruments all of which
are now in our product catalogue. They include scissors, forceps
for capsulorhexis and for folding and inserting IOLs, diamond knives,
as well as a keratoscope and tips and handpieces for irrigation
and aspiration, to name just a few," Mr. Waldock told EuroTimes.
A
Family Affair
Since Mr. Waldock took over Duckworth and Kent, it has become very
much a family affair. His sons Andrew and Adrian are stockholders
and members of the board. Like his father, Adrian is an engineer,
while Andrew is a consultant ophthalmologist at Bristol Hospital
in the UK, whose specialties include cataract, glaucoma and corneal
surgery.
"Andrew
has no role in running the company, but he has proved to be very
helpful to us. He can give us the surgeons' view of a new product
and can tell us in detail what a surgeon is trying to achieve and
what problems he may encounter. He also comes to Baldock frequently
to give lectures to the staff on various aspects of ophthalmology."
An
International Marketplace
Currently, the major markets for the instruments that Duckworth
and Kent produces are the United States, Japan and the United Kingdom
The USA has proved to be a very important outlet, thanks to the
activities of the company's marketing office in St. Louis, Missouri.
It was established in 1993 under the guidance of Michelle Glossip,
who accepted the chance to set up what seemed to be a very challenging
opportunity for marketing the British company's product line on
the other side of the Atlantic.
"Michelle's
contributions have been very significant for us and our future.
Over the last seven years, she has helped change our image from
a company that was not known at all in the United States to the
extent that we are now so well recognised and respected that it
is out biggest market."
However,
although the UK is part of the European Union, that connection has
still not paid off to the economic benefit of Duckworth and Kent,
Mr. Waldock told EuroTimes.
"There
are two reasons for that. The UK is still the only country in Europe
which has still not agreed to use the Euro as the currency of choice
for carrying out commercial transactions and the second is that
the Pound Sterling is very strong. This has meant that in comparison,
the value of the Euro has declined by 20% since it was introduced,
which in turn means that our products cost 20 % more in Europe than
they would have if we had embraced the Euro."
Growing
At Its Own Pace
With its present markets, Duckworth and Kent finds itself in a financially
comfortable condition and expects to grow even more in the next
ten years as more and more cataract and refractive surgeons require
new and improved instruments to keep abreast of those new and continually
expanding fields. At the same time, Mr. Waldock admits that although
some observers might suggest that the company might not have grown
to the extent that it could have done, he doesn't think that is
a bad thing.
"I
cannot dispute that viewpoint, and recognise that our company could
be perhaps 10 times the size that it is now if we had done things
differently. However, I am totally responsible for the control and
financial dealings of Duckworth and Kent and it is up to me to approach
the banks for enough financing to allow us to grow at a rate which
allows us to do the things we do best, that is providing the best
instruments possible to ophthalmic surgeons throughout the world.
I could have gone to venture capitalists for additional financial
backing, and I have been approached by several over the last few
years, but that option still doesn't have much appeal for me," he
says.
Obviously
what has brought Duckworth and Kent to its present state of financial
well being is the growing acceptance of its burgeoning catalogue
of ophthalmic surgical instruments, in almost every imaginable category
and all made primarily of titanium. The more than 1000-strong list
of products is seemingly endless; forceps, diamond knives, specula,
needle holders, corneal markers, nucleus dividers, keratometers,
lid clamps, hooks, scissors, membrane punchers, I/A and bi-manuals,
etc. etc. etc.
When
asked whether he and the company he owns and directs has an overall
guiding philosophy, he told EuroTimes:
"Our
ultimate goal is to produce perfect instruments to enable the surgeon
to do perfect surgery, and that is probably an impossible target.
However, we are perfectionists when we set out to engineer, develop
and produce instruments for the many and diverse needs of ophthalmic
surgeons. If we have a motto that guides us in what we do, I think
it can be put into three simple words, "quality, quality, quality".